|
CN107216388A
|
|
A kind of preparation method and purposes for treating hepatitis C virus cytotoxic drug
|
|
CN107286238A
|
|
Preparation, detection and the application of HCV-Ab IgG wide spectrum neutralizing antibody
|
|
CN107286237A
|
|
The acquisition and application of a kind of anti-HCV
|
|
CN107118273A
|
|
A kind of full people source anticomplement factor H antibody
|
|
CN106519031A
|
|
CFH antibody related with alternative pathway
|
|
CN106519030A
|
|
Complement factor H inhibitor and application related to same
|
|
CN106636392A
|
|
Method for detecting tumor microenvironment-associated antigen expression
|
|
CN106432486A
|
|
Fully human anti-rabies virus neutralizing antibody and application thereof
|
|
CN106432485A
|
|
Fully-humanized rabies virus resisting neutralizing antibody
|
|
CN106749644A
|
|
A kind of neutralizing antibody TRN1001 of full people source HCV-Ab IgG
|
|
CN106749645A
|
|
A kind of neutralizing antibody of full people source anti-hepatitis c virus
|
|
CN106544414A
|
|
A kind of method of STAT3 and LCK in detection brain metastasis sample
|
|
CN103145834A
|
|
Antibody humanization transformation method
|
|
CN103910796A
|
|
Completely humanized neutralizing antibody for anti-rabies viruses
|
